Karel A. Dicke

Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck

Roy S. Herbst, Matthew A. Arquette, Dong M. Shin et al. · Journal of Clinical Oncology · 2005 · 402 citations · Full text

Risk factors for acute graft‐versus‐host disease

Robert Peter Gale, Mortimer M. Bortin, D. W. van Bekkum et al. · British Journal of Haematology · 1987 · 358 citations

High-Dose Cyclophosphamide, Carmustine, and Etoposide and Autologous Bone Marrow Transplantation for Relapsed Hodgkin's Disease

Sundar Jagannath, Karel A. Dicke, Jamés O. Armitage et al. · Annals of Internal Medicine · 1986 · 210 citations

Cell Therapy, Immunology, Thirty Patients +17

Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?

Olle Ringdén, MM Horowitz, Paul M. Sondel et al. · Blood · 1993 · 168 citations · Full text

AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED ADULT ACUTE LEUKÆMIA

Karel A. Dicke, Gary Spitzer, L. J. Peters et al. · The Lancet · 1979 · 148 citations

Transplantation, Marrow Transplantation, Stem Cell Transplantation +3